This site is intended for U.S. healthcare professionals.
Menu
Close
Menu
Close
RCC is a group of diseases that occurs in the renal epithelium. The most common subtype is clear cell RCC (ccRCC), which represents ~70% of adult RCCs. ccRCC has the highest risk of metastasis, and so it is considered advanced RCC. Approximately 30% of RCC patients present with advanced RCC at the time of diagnosis.1-4
While there are rarely signs or symptoms in the earlier stages of RCC, possible signs of advanced disease may include blood in the urine, lower back pain on one side, a mass on the side or lower back, fatigue, loss of appetite, weight loss, persistent fever that is not caused by an infection, and anemia.5
Find materials for you and your patients
View videos and on-demand webinars
References
American Cancer Society. What is kidney cancer? Revised May 5, 2020. Accessed November 9, 2021. https://www.cancer.org/cancer/kidney-cancer/about/What-is-kidney-cancer.html
Nabi S, Kessler ER, Bernard B, Flaig TW, Lam ET. Renal cell carcinoma: a review of biology and pathophysiology. F1000Res. 2018;7:307.
Brufau BP, Cerqueda CS, Villalba LB, Izquierdo RS, González BM, Molina CN. Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT. Radiographics. 2013;33(6):1691-1716.
Jonasch E, Walker CL, Rathmell WK. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat Rev Nephrol. 2021;17(4):245-261.
American Cancer Society. Signs and Symptoms. Revised February 1, 2020. Accessed November 9, 2021. https://www.cancer.org/cancer/kidney-cancer/detection-diagnosis-staging/signs-and-symptoms
To report an adverse event, please call 1-800-438-1985
Pfizer for Professionals 1-800-505-4426
This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.
© 2024 Pfizer Inc. All rights reserved.